Skip to content

Clinical trials

Observational Disease Progression trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Observational Country / region: China Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20112
20132
20152
20172
20183
20202
20211
20225
20233
20244
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting14
Completed8
Unknown status8
Not yet recruiting4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking Union Medical College Hospital3
Peking University People's Hospital3
Fudan University2
Second Xiangya Hospital of Central South University2
Bayer1
Beijing Friendship Hospital1
Beijing Municipal Administration of Hospitals1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University1
Eli Lilly and Company1
Henan Provincial People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression37
Coronary Artery Disease3
Coronary Restenosis3
Coronary Stenosis3
Inflammation3
Alzheimer Disease2
Carcinoma, Non-Small-Cell Lung2
Cognitive Dysfunction2
Dementia2
Ischemic Stroke2

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.